United States Sterilization Equipment Market Outlook to 2021

Size: px
Start display at page:

Download "United States Sterilization Equipment Market Outlook to 2021"

Transcription

1 United States Sterilization Equipment Market Outlook to 2021

2 United States Sterilization Equipment Market Outlook to 2021 BioPortfolio has been marketing business and market research reports from selected publishers for over fifteen years. BioPortfolio offers a personal service to our customers with dedicated research managers who will work with you to source the best report for your needs. Based in the UK, BioPortfolio is well positioned to coordinate our customers' orders sourced from over 50 global report publishers. We are pleased to present details of this report to assist your buying decision and administrative process. You will find easy-to-use How To Buy information on the last page of this document. We look forward to being of service to you. If you have bulk and/or recurring requirements, please get in touch - we can liaise with publishers to obtain sample pages and negotiate discounts on your behalf. Phone: +44 (0) or 2

3 United States Sterilization Equipment Market Outlook to 2021 United States Sterilization Equipment Market Outlook to 2021 Summary GlobalData s new report, "United States Sterilization Equipment Market Outlook to 2021", provides key market data on the United States Sterilization Equipment market. The report provides value, in millions of US dollars, volume (in units) and average price data (in US dollars), within market segments - Chemical Sterilizers, Physical Sterilizers and Ultraviolet Sterilizers. The report also provides company shares and distribution shares data for the market category, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is available in the report. Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis. Scope - Market size for Sterilization Equipment market segments - Chemical Sterilizers, Physical Sterilizers and Ultraviolet Sterilizers. - Annualized market revenues (USD million), volume (units) and average selling price ($) data for each of the market categories. Data is provided from 2007 to 2014 and forecast to company shares and distribution shares data for Sterilization Equipment market. - Global corporate-level profiles of key companies operating within the United States Sterilization Equipment market. - Key players covered include Steris Corporation, Advanced Sterilization Products Services Inc., Getinge AB and others. Reasons to buy - Develop business strategies by identifying the key market segments poised for strong growth in the future. - Develop market-entry and market expansion strategies. - Design competition strategies by identifying who-stands-where in the market. - Develop investment strategies by identifying the key market segments expected to register strong growth in the near future. - What are the key distribution channels and what s the most preferred mode of product distribution - Identify, understand and capitalize. 3

4 Additional Details Publisher : Global Data Reference : GDMECC1595DB Number of Pages : 99 Report Format : PDF Publisher Information : 4

5 Table Of Contents for United States Sterilization Equipment Market Outlook to Table of Contents1 Table of Contents 21.1 List of Tables 61.2 List of Figures 62 Introduction 72.1 What Is This Report About? 72.2 Sterilization Equipment Market Segmentation 72.3 Definitions of Markets Covered in the Report 83 Sterilization Equipment Market, United States 93.1 Sterilization Equipment Market, United States, Revenue ($m), Sterilization Equipment Market, United States, Revenue ($m), Chemical Sterilizers Market, United States, Revenue ($m), by Segment, Chemical Sterilizers Market, United States, Revenue ($m), by Segment, Sterilization Equipment Market, United States, Volume (Units), Sterilization Equipment Market, United States, Volume (Units), Chemical Sterilizers Market, United States, Volume (Units), by Segment, Chemical Sterilizers Market, United States, Volume (Units), by Segment, Sterilization Equipment Market, United States, Average Price ($), Sterilization Equipment Market, United States, Distribution Share by Revenue ($m), Sterilization Equipment Market, United States, Company Share by Revenue ($m), Overview of Key Companies in United States, Sterilization Equipment Market Steris Corporation Company Overview Advanced Sterilization Products Services Inc Company Overview Tuttnauer USA Co. Ltd Company Overview Getinge AB Company Overview M Health Care Ltd Company Overview Belimed Sauter AG Company Overview 325 Sterilization Equipment Market Pipeline Products 336 Financial Deals Landscape Acquisition Steris to Acquire General Econopak for USD175 Million Asset Transactions Crosstex International to Acquire Sterility Assurance Products Division of North American Science Associates Xellia Pharma Acquires Manufacturing Facilities from Hikma Pharma Medline Industries Acquires Assets of SwabFlush from ICU Medical for USD27 Million Equity Offerings Pure Bioscience Raises USD6 Million in Private Placement of Shares Private Equity RoundTable Healthcare Acquires TIDI Products from J.H. Whitney 437 Recent Developments Corporate Communications Sep 29, 2015: Anacor Pharmaceuticals Announces Presentations of Crisaborole Topical Ointment, 2% Phase 3 Pivotal Data at Two Upcoming Medical Conferences Aug 07, 2015: Cantel Medical Appoints David Rosen as President, Asia Pacific and Emerging Markets Jul 31, 2015: Pure Bioscience Announces Restructuring Of Its Finance Department Jun 29, 2015: Cantel Medical Appoints David C. Hemink as President, Medivators and Michael G. Spicer as President, Americas Sales and Global Service Jun 19, 2015: PuriCore announces Board Changes Jun 03, 2015: Puritan Welcomes New Director of Sales, West Coast Mar 19, 2015: Cantel Medical Announces Appointment Of Dr. Laura Forese To Its Board Of Directors Mar 10, 2015: Maetrics announces new president Financial Announcements Dec 10, 2015: Cantel Medical Reports Record Results For The First Quarter Ended October 31, Dec 08, 2015: Studies Demonstrate Broadening Clinical Utility of biotheranostics Breast Cancer Index Molecular Test in the Extended Endocrine Therapy Setting Dec 08, 2015: Medovex Completes Multi-Unit Streamline IV Suspension System Sale to Major Regional Hospital Dec 07, 2015: Foundation Medicine Announces Presentations at the 2015 San Antonio Breast Cancer Symposium Dec 07, 2015: Agendia s MammaPrint and BluePrint Breast Cancer Tests to Be Highlighted at San Antonio Symposium Dec 04, 2015: BioVentrix Announces Milestone Achievement of its First Interventional Heart Failure Procedure for LV Volume Reduction in a Pre-Clinical Model Dec 04, 2015: Cerus Announces Mississippi Valley Regional Blood Center Enters Into Agreement for the Use of INTERCEPT Platelets and Plasma Nov 10, 2015: Independent study of Cloud DX wrist cuff blood pressure monitor shown to be accurate compared to gold-standard measures by intraarterial pressure catheter in clinical setting Nov 05, 2015: Atrion Reports Third Quarter 2015 Results Sep 29, 2015: Motif Announces Presentation of Two Posters on Iclaprim at ID Week Sep 29, 2015: Cantel Medical Reports Record Results For The Fourth Quarter Ended July 31, Aug 04, 2015: Atrion Reports Second Quarter 2015 Results Jul 29, 2015: Hospira Reports Second-Quarter 2015 Results Jun 11, 2015: PURE Bioscience Reports 2015 Fiscal Third Quarter and Nine-Month Financial Results Jun 01, 2015: OncoGenex Announces Data from Borealis-1 Trial Showing Clinical Benefit with Apatorsen in Metastatic Bladder Cancer May 06, 2015: Atrion Reports First Quarter Results Apr 28, 2015: Hospira Reports First-Quarter 2015 Results Apr 27, 2015: Medtronic Announces Consent Decree with FDA for the Synchromed Drug Infusion System Apr 16, 2015: Ethicon Receives Prestigious Award for ENSEAL G2 Articulating Tissue Sealer Innovation in Design, Sustainability Improvements 5

6 Mar 04, 2015: PURE Bioscience Reports 2015 Fiscal Second Quarter and Six-Month Financial Results Feb 23, 2015: Atrion Reports Fourth Quarter and Full Year 2014 Results Feb 20, 2015: Medigene receives positive decision on marketing authorisation for Veregen in 8 additional European countries Legal And Regulatory Jun 24, 2015: TOMI Receives EPA Registration for Its Patented BIT Technology May 01, 2015: Hospira Statement On FDA's Final Biosimilar Guidance Documents Apr 13, 2015: Hope for Greater Access for Patients to Biosimilar Medicines Feb 27, 2015: Hospira Provides Update On FDA Inspection At Its Facilities In US And India Other Significant Developments Jan 12, 2016: New PDI Visual Resource Highlights How Proper Disinfection Can Reduce Central Lineassociated Bloodstream Infections Sep 28, 2015: Esperion Therapeutics Provides Further Updates on ETC-1002 Global Phase 3 Strategy Following Receipt of End-of-Phase 2 Meeting Minutes Jul 16, 2015: Delafield Solutions Joins With Pocono Medical Center to Demonstrate Effectiveness of Continuous Area Disinfection Jun 03, 2015: Halyard Health Signs First GPO Contract as Independent Company Mar 31, 2015: Halyard Health Signs First GPO Contracts as Independent Company: Leader in Sterilization Wrap, Facial Protection and Respiratory Health Awarded Contract with HealthTrust Mar 03, 2015: Atrion Declares Quarterly Cash Dividend Feb 19, 2015: Getinge Receives Double if Design Award for the Innovative User-Interface CENTRIC and Product Design of Getinge ProSeal Product News Jan 20, 2016: rfxcel Transforms Global Compliance and Serialization With Release of Next Generation Platform Nov 24, 2015: NuShield Provides Health Care Facilities with Germ Fighting Solution Technology Jun 26, 2015: First Hospital Light Fixture to Kill Bacteria Safely and Continuously Becomes Commercially Available in U.S. and Canada Jun 17, 2015: Puritan Medical Products Company updates Customers with more details about the final decision of the European Patent Office on Copan's European Patent EP B Jun 15, 2015: 3M/Ivera Medical & Catheter Connections Settle Patent Infringement Litigation Apr 15, 2015: Crosstex/SPSmedical Launches SANI ProZyme Enzymatic Detergent and SANI Glut Glutaraldehyde 3% Solution Strategy And Business Planning Sep 28, 2015: Clinical Data Presented On Binimetinib And Encorafenib In Melanoma Jun 08, 2015: Massachusetts Life Sciences Center and Dana-Farber Cancer Institute announce official opening of Dana- Farber's Molecular Cancer Imaging Facility 948 Appendix Research Methodology Coverage Secondary Research Primary Research Company Share Analysis Distribution Share Analysis GlobalData Consulting Contact Us Disclaimer 99 6

7 List Of Tables in United States Sterilization Equipment Market Outlook to List of Tables Table 1: Sterilization Equipment Market, United States, Revenue ($m), USD Constant, Historic, Table 2: Sterilization Equipment Market, United States, Revenue ($m), USD Constant, Forecast, Table 3: Chemical Sterilizers Market, United States, Revenue ($m), USD Constant, Historic, Table 4: Chemical Sterilizers Market, United States, Revenue ($m), USD Constant, Forecast, Table 5: Sterilization Equipment Market, United States, Volume (Units), Historic, Table 6: Sterilization Equipment Market, United States, Volume (Units), Forecast, Table 7: Chemical Sterilizers Market, United States, Volume (Units), Historic, Table 8: Chemical Sterilizers Market, United States, Volume (Units), Forecast, Table 9: Sterilization Equipment Market, United States, Average Price ($), Historic, Table 10: Sterilization Equipment Market, United States, Average Price ($), Forecast, Table 11: Sterilization Equipment Market, United States, Distribution Share by Revenue ($m), USD Constant, Table 12: Sterilization Equipment Market, United States, Company Share by Revenue ($m), USD Constant, Table 13: Sterilization Equipment Market Pipeline Products 33 Table 14: Steris to Acquire General Econopak for USD175 Million 34 Table 15: Crosstex International to Acquire Sterility Assurance Products Division of North American Science Associates 36 Table 16: Xellia Pharma Acquires Manufacturing Facilities from Hikma Pharma 38 Table 17: Industries Acquires Assets of SwabFlush from ICU Medical for USD27 Million 40 Table 18: Pure Bioscience Raises USD6 Million in Private Placement of Shares 42 Table 19: RoundTable Healthcare Acquires TIDI Products from J.H. Whitney 43 7

8 List Of Figures, Charts and Diagrams in United States Sterilization Equipment Market Outlook to List of Figures Figure 1: Sterilization Equipment Market, United States, Revenue ($m), USD Constant, Historic, Figure 2: Sterilization Equipment Market, United States, Revenue ($m), USD Constant, Forecast, Figure 3: Chemical Sterilizers Market, United States, Revenue ($m), USD Constant, Historic, Figure 4: Chemical Sterilizers Market, United States, Revenue ($m), USD Constant, Forecast, Figure 5: Sterilization Equipment Market, United States, Volume (Units), Historic, Figure 6: Sterilization Equipment Market, United States, Volume (Units), Forecast, Figure 7: Chemical Sterilizers Market, United States, Volume (Units), Historic, Figure 8: Chemical Sterilizers Market, United States, Volume (Units), Forecast, Figure 9: Sterilization Equipment Market, United States, Company Share (%)

9 How to Buy... United States Sterilization Equipment Market Outlook to 2021 Option 1 - Online Go to our website and pay online with any major debit or credit card: Option 2 - Request a Proforma Invoice Fill in the details below, and either Scan this page and it to us at or Fax it to us at +44 (0) We will send you a Proforma Invoice and deliver your report on settlement. Your Name: Job Title: Your Your Contact Phone: Company Name: Address: Post/Zip Code: Country: P.O. Number: Any Other Instructions: Pricing Options: (please tick one) $4995 Single User Price $9990 Site License Price $14985 Enterprise License Price Payment Options: (please tick one) Online Credit Card (we will you the invoice with a payment link) Direct Wire Transfer (we will you the invoice with our bank details) Authorising Signature: Option 3 - Phone Us on +44 (0) We will be delighted to give you our personal attention. 9

Mesa Laboratories, Inc. (MLAB) - Medical Equipment - Deals and Alliances Profile

Mesa Laboratories, Inc. (MLAB) - Medical Equipment - Deals and Alliances Profile Mesa Laboratories, Inc. (MLAB) - Medical Equipment - Deals and Alliances Profile Mesa Laboratories, Inc. (MLAB) - Medical Equipment - Deals and Alliances Profile BioPortfolio has been marketing business

More information

Compression Therapy - Medical Devices Pipeline Assessment, 2017

Compression Therapy - Medical Devices Pipeline Assessment, 2017 Compression Therapy - Medical Devices Pipeline Assessment, 2017 Compression Therapy - Medical Devices Pipeline Assessment, 2017 BioPortfolio has been marketing business and market research reports from

More information

Mesa Laboratories, Inc. (MLAB) - Medical Equipment - Deals and Alliances Profile

Mesa Laboratories, Inc. (MLAB) - Medical Equipment - Deals and Alliances Profile Mesa Laboratories, Inc. (MLAB) - Medical Equipment - Deals and Alliances Profile Mesa Laboratories, Inc. (MLAB) - Medical Equipment - Deals and Alliances Profile BioPortfolio has been marketing business

More information

Collegium Pharmaceutical Inc (COLL) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Collegium Pharmaceutical Inc (COLL) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Collegium Pharmaceutical Inc (COLL) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Collegium Pharmaceutical Inc (COLL) - Pharmaceuticals & Healthcare - Deals and Alliances Profile The Business

More information

Nektar Therapeutics (NKTR) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Nektar Therapeutics (NKTR) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Nektar Therapeutics (NKTR) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Nektar Therapeutics (NKTR) - Pharmaceuticals & Healthcare - Deals and Alliances Profile BioPortfolio has been marketing

More information

ConvaTec Group Plc - Pharmaceuticals & Healthcare - Deals and Alliances Profile

ConvaTec Group Plc - Pharmaceuticals & Healthcare - Deals and Alliances Profile ConvaTec Group Plc - Pharmaceuticals & Healthcare - Deals and Alliances Profile ConvaTec Group Plc - Pharmaceuticals & Healthcare - Deals and Alliances Profile BioPortfolio has been marketing business

More information

Acadia Pharmaceuticals Inc. (ACAD) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Acadia Pharmaceuticals Inc. (ACAD) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Acadia Pharmaceuticals Inc. (ACAD) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Acadia Pharmaceuticals Inc. (ACAD) - Pharmaceuticals & Healthcare - Deals and Alliances Profile BioPortfolio

More information

Karo Pharma AB (KARO) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Karo Pharma AB (KARO) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Karo Pharma AB (KARO) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Karo Pharma AB (KARO) - Pharmaceuticals & Healthcare - Deals and Alliances Profile BioPortfolio has been marketing business

More information

Starpharma Holdings Limited (SPL) - Medical Equipment - Deals and Alliances Profile

Starpharma Holdings Limited (SPL) - Medical Equipment - Deals and Alliances Profile Starpharma Holdings Limited (SPL) - Medical Equipment - Deals and Alliances Profile Starpharma Holdings Limited (SPL) - Medical Equipment - Deals and Alliances Profile BioPortfolio has been marketing business

More information

Starpharma Holdings Limited (SPL) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Starpharma Holdings Limited (SPL) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Starpharma Holdings Limited (SPL) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Starpharma Holdings Limited (SPL) - Pharmaceuticals & Healthcare - Deals and Alliances Profile BioPortfolio

More information

Emcure Pharmaceuticals Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Emcure Pharmaceuticals Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile Emcure Pharmaceuticals Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile Emcure Pharmaceuticals Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile BioPortfolio has been marketing

More information

Mindray Medical International Limited (MR) - Medical Equipment - Deals and Alliances Profile

Mindray Medical International Limited (MR) - Medical Equipment - Deals and Alliances Profile Mindray Medical International Limited (MR) - Medical Equipment - Deals and Alliances Profile Mindray Medical International Limited (MR) - Medical Equipment - Deals and Alliances Profile BioPortfolio has

More information

Bessemer Venture Partners - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Bessemer Venture Partners - Pharmaceuticals & Healthcare - Deals and Alliances Profile Bessemer Venture Partners - Pharmaceuticals & Healthcare - Deals and Alliances Profile Bessemer Venture Partners - Pharmaceuticals & Healthcare - Deals and Alliances Profile BioPortfolio has been marketing

More information

North China Pharmaceutical Group Corp. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

North China Pharmaceutical Group Corp. - Pharmaceuticals & Healthcare - Deals and Alliances Profile North China Pharmaceutical Group Corp. - Pharmaceuticals & Healthcare - Deals and Alliances Profile North China Pharmaceutical Group Corp. - Pharmaceuticals & Healthcare - Deals and Alliances Profile BioPortfolio

More information

Median Kliniken GmbH & Co. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Median Kliniken GmbH & Co. - Pharmaceuticals & Healthcare - Deals and Alliances Profile Median Kliniken GmbH & Co. - Pharmaceuticals & Healthcare - Deals and Alliances Profile Median Kliniken GmbH & Co. - Pharmaceuticals & Healthcare - Deals and Alliances Profile BioPortfolio has been marketing

More information

Natera, Inc. (NTRA) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Natera, Inc. (NTRA) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Natera, Inc. (NTRA) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Natera, Inc. (NTRA) - Pharmaceuticals & Healthcare - Deals and Alliances Profile BioPortfolio has been marketing business

More information

Pharmaxis Ltd (PXS) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Pharmaxis Ltd (PXS) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Pharmaxis Ltd (PXS) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Pharmaxis Ltd (PXS) - Pharmaceuticals & Healthcare - Deals and Alliances Profile BioPortfolio has been marketing business

More information

Bionure Farma SL - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Bionure Farma SL - Pharmaceuticals & Healthcare - Deals and Alliances Profile Bionure Farma SL - Pharmaceuticals & Healthcare - Deals and Alliances Profile Bionure Farma SL - Pharmaceuticals & Healthcare - Deals and Alliances Profile BioPortfolio has been marketing business and

More information

DNA2.0 Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile

DNA2.0 Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile DNA2.0 Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile DNA2.0 Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile BioPortfolio has been marketing business and market research

More information

Becton, Dickinson and Company (BDX) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Becton, Dickinson and Company (BDX) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Becton, Dickinson and Company (BDX) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Becton, Dickinson and Company (BDX) - Pharmaceuticals & Healthcare - Deals and Alliances Profile BioPortfolio

More information

Glenmark Pharmaceuticals Inc., USA - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Glenmark Pharmaceuticals Inc., USA - Pharmaceuticals & Healthcare - Deals and Alliances Profile Glenmark Pharmaceuticals Inc., USA - Pharmaceuticals & Healthcare - Deals and Alliances Profile Glenmark Pharmaceuticals Inc., USA - Pharmaceuticals & Healthcare - Deals and Alliances Profile BioPortfolio

More information

Phone: +44 (0) or BioPortfolio Limited

Phone: +44 (0) or   BioPortfolio Limited Global Laser Holographic Display Market by Product (Medical Scanners, Digital Signage, Kiosk, Notebook), by Application (Medical, Commercial, Industrial, Defense, Consumer Electronics), by Geography -

More information

Bioton SA (BIO) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Bioton SA (BIO) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Bioton SA (BIO) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Bioton SA (BIO) - Pharmaceuticals & Healthcare - Deals and Alliances Profile BioPortfolio has been marketing business and market

More information

DaVita HealthCare Partners Inc. (DVA) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

DaVita HealthCare Partners Inc. (DVA) - Pharmaceuticals & Healthcare - Deals and Alliances Profile DaVita HealthCare Partners Inc. (DVA) - Pharmaceuticals & Healthcare - Deals and Alliances Profile DaVita HealthCare Partners Inc. (DVA) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Sector

More information

Vanderbilt University - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Vanderbilt University - Pharmaceuticals & Healthcare - Deals and Alliances Profile Vanderbilt University - Pharmaceuticals & Healthcare - Deals and Alliances Profile Vanderbilt University - Pharmaceuticals & Healthcare - Deals and Alliances Profile Sector Publishing Intelligence Limited

More information

Faes Farma SA (FAE) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Faes Farma SA (FAE) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Faes Farma SA (FAE) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Faes Farma SA (FAE) - Pharmaceuticals & Healthcare - Deals and Alliances Profile BioPortfolio has been marketing business

More information

Paramount Mining Corporation Limited (PCP) - Metals and Mining - Deals and Alliances Profile

Paramount Mining Corporation Limited (PCP) - Metals and Mining - Deals and Alliances Profile Paramount Mining Corporation Limited (PCP) - Metals and Mining - Deals and Alliances Profile Paramount Mining Corporation Limited (PCP) - Metals and Mining - Deals and Alliances Profile Sector Publishing

More information

Vorwerk and Co. KG - Strategy, SWOT and Corporate Finance Report

Vorwerk and Co. KG - Strategy, SWOT and Corporate Finance Report Vorwerk and Co. KG - Strategy, SWOT and Corporate Finance Report Vorwerk and Co. KG - Strategy, SWOT and Corporate Finance Report The Business Research Store is run by Sector Publishing Intelligence Ltd.

More information

The Walt Disney Company - Strategy, SWOT and Corporate Finance Report

The Walt Disney Company - Strategy, SWOT and Corporate Finance Report The Walt Disney Company - Strategy, SWOT and Corporate Finance Report The Walt Disney Company - Strategy, SWOT and Corporate Finance Report The Business Research Store is run by Sector Publishing Intelligence

More information

Gap, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

Gap, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Gap, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Gap, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Sector Publishing Intelligence

More information

Surgical Sutures Market By Product Type [Automated Suturing Devices (Disposable Automated Suturing Devices, And Re-Usable Automated Suturing

Surgical Sutures Market By Product Type [Automated Suturing Devices (Disposable Automated Suturing Devices, And Re-Usable Automated Suturing Surgical Sutures Market By Product Type [Automated Suturing Devices (Disposable Automated Suturing Devices, And Re-Usable Automated Suturing Devices), and Sutures (Sutures by Type (Absorbable & Non-Absorbable),

More information

Kohler Co. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

Kohler Co. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Kohler Co. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Kohler Co. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Sector Publishing Intelligence

More information

McCain Foods Limited, Inc. - Strategic SWOT Analysis Review

McCain Foods Limited, Inc. - Strategic SWOT Analysis Review McCain Foods Limited, Inc. - Strategic SWOT Analysis Review McCain Foods Limited, Inc. - Strategic SWOT Analysis Review Sector Publishing Intelligence Limited (SPi) has been marketing business and market

More information

Maruti Suzuki India Limited Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

Maruti Suzuki India Limited Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Maruti Suzuki India Limited Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Maruti Suzuki India Limited Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment

More information

Critical Limb Ischemia - Pipeline Review, H1 2017

Critical Limb Ischemia - Pipeline Review, H1 2017 Critical Limb Ischemia - Pipeline Review, H1 2017 Critical Limb Ischemia - Pipeline Review, H1 2017 BioPortfolio has been marketing business and market research reports from selected publishers for over

More information

Generics Series: Authorized Generics Analysis Stemming the Generics Tide

Generics Series: Authorized Generics Analysis Stemming the Generics Tide Generics Series: Authorized Generics Analysis Stemming the Generics Tide Report summary An overview of the authorized generics landscape, including drivers and resistors for both branded and generics players

More information

Management to Host Conference Call at 8:30 a.m. ET today

Management to Host Conference Call at 8:30 a.m. ET today Aclaris Therapeutics Reports Second Quarter 2016 Financial Results August 11, 2016 7:01 AM ET Management to Host Conference Call at 8:30 a.m. ET today MALVERN, Pa., Aug. 11, 2016 (GLOBE NEWSWIRE) -- (NASDAQ:ACRS),

More information

April By Type of Approach- Transfemoral and Transapical. By Region- North America, Europe, APAC and RoW

April By Type of Approach- Transfemoral and Transapical. By Region- North America, Europe, APAC and RoW Global Transcatheter Aortic Valve Replacement (TAVR) Market: Analysis By Type of Approach (Transfemoral and Transapical), By Region, By Country: Opportunities and Forecast (2017-2022) By Type of Approach-

More information

PwC Deals $42B. Global Pharma & Life Sciences Deals Insights Q Update

PwC Deals $42B. Global Pharma & Life Sciences Deals Insights Q Update PwC Deals Q3 16 Update Executive summary Global Pharma and Life Sciences (PLS) deal activity declined both in volume and value this quarter compared to the prior quarter and Q3 15. The considerable decrease

More information

PROMETIC REPORTS 2017 THIRD QUARTER HIGHLIGHTS AND FINANCIAL RESULTS

PROMETIC REPORTS 2017 THIRD QUARTER HIGHLIGHTS AND FINANCIAL RESULTS PRESS RELEASE FOR IMMEDIATE RELEASE PROMETIC REPORTS 2017 THIRD QUARTER HIGHLIGHTS AND FINANCIAL RESULTS US $80 million (CAD $100 million) line of credit secured from Structured Alpha LP Plasminogen BLA

More information

FY rd Quarter Financial Results

FY rd Quarter Financial Results FY2012 3 rd Quarter Financial Results April 1 December 31, 2011 KONAMI CORPORATION February 2, 2012 Cautionary statement with respect to forward-looking statements Statements made in this presentation

More information

Implantable Drug Delivery Devices Market - Global Industry Analysis, Size, Share, Trends And Forecast,

Implantable Drug Delivery Devices Market - Global Industry Analysis, Size, Share, Trends And Forecast, Transparency Market Research Implantable Drug Delivery Devices Market - Global Industry Analysis, Size, Share, Trends And Forecast, 2012 2018 Buy Now Request Sample Published Date: Mar 2013 Single User

More information

A Brief Introduction to the Regulatory Environment of Medical Device Supervision. CFDA Department of Legal Affairs Liu Pei

A Brief Introduction to the Regulatory Environment of Medical Device Supervision. CFDA Department of Legal Affairs Liu Pei A Brief Introduction to the Regulatory Environment of Medical Device Supervision CFDA Department of Legal Affairs Liu Pei Development Trend of Medical Device Industry Development Opportunities of Medical

More information

Capcom Co., Ltd. Tokyo and Osaka Exchanges, First Section, rd Quarter Report Fiscal year ending March 31, 2010

Capcom Co., Ltd. Tokyo and Osaka Exchanges, First Section, rd Quarter Report Fiscal year ending March 31, 2010 Capcom Co., Ltd. Tokyo and Osaka Exchanges, First Section, 9697 3rd Quarter Report Fiscal year ending March 31, 2010 Precautions Concerning Forward-looking Statements Strategies, plans, outlooks and other

More information

Global Source Ventures, LLC Introduction. Antonius Schuh Managing Partner Stephen Zaniboni Managing Partner

Global Source Ventures, LLC Introduction. Antonius Schuh Managing Partner Stephen Zaniboni Managing Partner Global Source Ventures, LLC Introduction Antonius Schuh Managing Partner Stephen Zaniboni Managing Partner Introduction to Global Source Ventures GSV provides seed capital to emerging companies with emphasis

More information

Shell s Journey to Mobility

Shell s Journey to Mobility Shell s Journey to Mobility Speakers: Yorinde Knegtering Business Analyst, IT Produce Hydrocarbons Prabhat Mishra Product Owner, PI Center of Excellence Definitions & cautionary note Reserves: Our use

More information

1 Table of Contents 1.1 List of Tables 1.2 List of Figures 2 Introduction 3 Global Neurostimulation Devices Market - An Overview 3.

1 Table of Contents 1.1 List of Tables 1.2 List of Figures 2 Introduction 3 Global Neurostimulation Devices Market - An Overview 3. 1 Table of Contents 1.1 List of Tables 1.2 List of Figures 2 Introduction 3 Global Neurostimulation Devices Market - An Overview 3.1 Spinal Cord Stimulator 3.2 Deep Brain Stimulator 3.3 Vagus Nerve Stimulator

More information

Fossa is Ready to Grab Large Markets

Fossa is Ready to Grab Large Markets Gloria Ro Kolb Fossa is Ready to Grab Large Markets 1. Large, profitable Markets Underserved 2. Innovative Products that can Serve Kidney Stone Sweeper is first out of five Capture attention of doctors/leaders

More information

Second Quarter CY 2012 Results. August 2, 2012

Second Quarter CY 2012 Results. August 2, 2012 Second Quarter CY 2012 Results August 2, 2012 1 Safe Harbor Disclosure Please review our SEC filings on Form 10-K and Form 10-Q The statements contained in this presentation that are not historical facts

More information

Active Cable TV Connections. Active Residential Cable Modem Customers. Page FIRST QUARTER REPORT

Active Cable TV Connections. Active Residential Cable Modem Customers. Page FIRST QUARTER REPORT 21-22 FIRST QUARTER REPORT Active Cable TV Connections AFN Cable connections in the business plan are projected to be 2,44 by July 22. As of October 31, 21, there are 1,895 connections, which means AFN

More information

Observations from Pharma

Observations from Pharma Observations from Pharma Indian Patent Enforcement in the Chemical Arts Gurmeet Kaur Sidhu, Senior Patent Litigation Counsel London, 26/9/11 a Novartis company The Indian Pharmaceutical sector: Overview

More information

Leader in Pharmaceutical Films

Leader in Pharmaceutical Films TSX-V: IGX OTCQX: IGXT Leader in Pharmaceutical Films Your Specialist in Contract Development & Manufacturing WE MAKE APPROVED DRUGS BETTER Our Mission We make approved drugs better, with next generation

More information

FY nd Quarter Financial Results

FY nd Quarter Financial Results FY2013 2 nd Quarter Financial Results April 1 September 30, 2012 KONAMI CORPORATION November 1, 2012 Cautionary statement with respect to forward-looking statements Statements made in this presentation

More information

For personal use only

For personal use only ASX ANNOUNCEMENT AGM PRESENTATION SYDNEY, Monday 21 November 2016: Cellmid Limited (ASX:CDY) provides the following presentation for the Annual General Meeting of the shareholders. End Contact: Maria Halasz,

More information

Fall State of the Industry Report UF SID MARTIN FLORIDA BIODATABASE

Fall State of the Industry Report UF SID MARTIN FLORIDA BIODATABASE Fall 2015 State of the Industry Report UF SID MARTIN FLORIDA BIODATABASE Industry Overview The expansion of Florida s biotech industry remains resilient with an overall growth rate of 92% in the number

More information

PRECISE MEDICAL Self-revealing case Handout #1

PRECISE MEDICAL Self-revealing case Handout #1 OBEA Conference May 23-24, 2015 Entrepreneurship as it Relates to Financial Literacy Grant Russell, Associate Director of Undergraduate Programs School of Accounting and Finance, University of Waterloo

More information

COURSE SCHEDULE

COURSE SCHEDULE 2018-2019 COURSE SCHEDULE Fall 1 Seven-Week: Aug. 27 Oct. 12, 2018 Business Formation & Structure -11:40am Legal & Regulatory Process ` Patent Business Formation & Structure -11:40am Research in, Business

More information

HBM Healthcare Investments Ltd Access to a Global and Diversified Private Equity Healthcare Portfolio

HBM Healthcare Investments Ltd Access to a Global and Diversified Private Equity Healthcare Portfolio HBM Healthcare Investments Ltd Access to a Global and Diversified Private Equity Healthcare Portfolio SECA conference Zurich, 3 July 2013 Dr. Andreas Wicki, CEO HBM at a Glance SIX-listed investment company

More information

Second Quarter 2013 Results August 1, 2013

Second Quarter 2013 Results August 1, 2013 Second Quarter 203 Results August, 203 2 Safe Harbor Disclosure Please review our SEC filings on Form 0-K and Form 0-Q The statements contained in this presentation that are not historical facts are forward-looking

More information

Mixed Signals: Understanding the Outlook for Pharma R&D Spending Through

Mixed Signals: Understanding the Outlook for Pharma R&D Spending Through Mixed Signals: Understanding the Outlook for Pharma R&D Spending Through 2015 www.pharmsource.com 1 Presenters Jim Miller President and Founder, PharmSource Saul Richmond, PhD Director of Market Intelligence,

More information

For personal use only

For personal use only 1 Agenda Welcome Executive Chairman s Address Chief Executive Officer s Address Annual General Meeting Executive Chairman s Address Presentation by Len Ainsworth 3 Harald Neumann Novomatic AG s CEO and

More information

FMC Technologies Overview Fourth Quarter Director, Investor Relations Matt Seinsheimer

FMC Technologies Overview Fourth Quarter Director, Investor Relations Matt Seinsheimer FMC Overview Fourth Quarter 2016 Director, Investor Relations Matt Seinsheimer +1 281.260.3665 matthew.seinsheimer@fmcti.com This presentation contains forward-looking statements intended to qualify for

More information

Results Presentation 2017 Second Quarter and Interim Results. 30 Aug, 2017

Results Presentation 2017 Second Quarter and Interim Results. 30 Aug, 2017 Results Presentation 2017 Second Quarter and Interim Results 30 Aug, 2017 Disclaimer This presentation is prepared by NetDragon Websoft Holdings Limited (the Company ) solely for information purposes and

More information

Opportunity in Small & Mid Cap

Opportunity in Small & Mid Cap Opportunity in Small & Mid Cap - A Private Equity Investing approach Presentation by Hiren Ved Alchemy Capital Management October 20 Presentation ti Path Investment Life Cycle Private equity opportunities

More information

Acquisition of GEODynamics. December 13, 2017

Acquisition of GEODynamics. December 13, 2017 Acquisition of GEODynamics December 13, 2017 Forward-looking Statements We include the following cautionary statement to take advantage of the "safe harbor" provisions of the Private Securities Litigation

More information

Financial Results Briefing Session

Financial Results Briefing Session Financial Results Briefing Session Six-Month Period Ended September 30, 2017 November 8, 2017 SQUARE ENIX HOLDINGS CO., LTD. Statements made in this document with respect to SQUARE ENIX HOLDINGS CO., LTD.

More information

1Q 2016 Results. Mermaid Maritime Plc. May 23, 2016

1Q 2016 Results. Mermaid Maritime Plc. May 23, 2016 Mermaid Maritime Plc 1Q 2016 Results May 23, 2016 Disclaimer: The information contained in this document is intended only for use during the presentation and should not be disseminated or distributed to

More information

Global Transcatheter Aortic Valve Replacement (TAVR) Market: Trends & Opportunities [ ]

Global Transcatheter Aortic Valve Replacement (TAVR) Market: Trends & Opportunities [ ] Global Transcatheter Aortic Valve Replacement (TAVR) Market: Trends & Opportunities [2013-18] Scope of the Report The report titled Transcatheter Aortic Valve Replacement Market (TAVR): Trends and Opportunities

More information

Capcom Co., Ltd. (Tokyo Stock Exchange, First Section, 9697) Financial Highlights for the Fiscal Year ended March 31, 2018

Capcom Co., Ltd. (Tokyo Stock Exchange, First Section, 9697) Financial Highlights for the Fiscal Year ended March 31, 2018 Capcom Co., Ltd. (Tokyo Stock Exchange, First Section, 9697) Financial Highlights for the Fiscal Year ended March 31, 2018 0 0 Forward-looking Statements Strategies, plans, outlooks and other statements

More information

ALANCO TECHNOLOGIES INC

ALANCO TECHNOLOGIES INC SECURITIES & EXCHANGE COMMISSION EDGAR FILING ALANCO TECHNOLOGIES INC Form: 8-K Date Filed: 2016-10-04 Corporate Issuer CIK: 98618 Copyright 2016, Issuer Direct Corporation. All Right Reserved. Distribution

More information

Textron Reports Third Quarter 2014 Income from Continuing Operations of $0.57 per Share, up 62.9%; Revenues up 18.1%

Textron Reports Third Quarter 2014 Income from Continuing Operations of $0.57 per Share, up 62.9%; Revenues up 18.1% Textron Reports Third Quarter Income from Continuing Operations of $0.57 per Share, up 62.9%; Revenues up 18.1% 10/17/ PROVIDENCE, R.I.--(BUSINESS WIRE)-- Textron Inc. (NYSE: TXT) today reported third

More information

SMART DUBAI INSPIRING NEW REALITIES

SMART DUBAI INSPIRING NEW REALITIES SMART DUBAI INSPIRING NEW REALITIES SMART DUBAI 2014-2017 2016 2013 Smart Government Smart Dubai & board formation 2000 E-Gov 2014 Smart Dubai Initiative 2021 Smart Dubai 2021 Smart Dubai is transforming

More information

For personal use only

For personal use only ASX Market Update Medibio Limited (ASX: MEB) 30 April 2016 Medibio Limited (ASX: MEB) ( Medibio or the Company ) is pleased to report on its activities for the March 2016 quarter. Highlights Successful

More information

Bayport Securitisation (RF) Ltd Investor Report February 2013

Bayport Securitisation (RF) Ltd Investor Report February 2013 Bayport Securitisation (RF) Ltd Investor Report February 2013 Financial statistics for the period ended February 2013 Feb 13 Jan 13 Dec 12 Nov 12 Oct 12 Sep 12 Aug 12 Jul 12 Jun 12 May 12 Apr 12 Mar 12

More information

Bayport Securitisation (RF) Ltd Investor Report May 2013

Bayport Securitisation (RF) Ltd Investor Report May 2013 Bayport Securitisation (RF) Ltd Investor Report May 2013 Financial statistics for the period ended May 2013 May 13 Apr 13 Mar 13 Feb 13 Jan 13 Dec 12 Nov 12 Oct 12 Sep 12 Aug 12 Jul 12 Jun 12 Performance

More information

Fourth Quarter 2013 Results. February 6, 2014

Fourth Quarter 2013 Results. February 6, 2014 Fourth Quarter 2013 Results February 6, 2014 Safe Harbor Disclosure Please review our SEC filings on Form 10-K and Form 10-Q The statements contained in this presentation that are not historical facts

More information

Digital Health Startups A FirstWord ExpertViews Dossier Report

Digital Health Startups A FirstWord ExpertViews Dossier Report AM PL E PA G ES S A G ES S A FirstWord ExpertViews Dossier Report Published Copyright 2016 Doctor s Guide Publishing Limited All rights reserved. No part of this publication may be reproduced or used in

More information

Abraxis: Emergent Life Science & Pharmaceutical Company

Abraxis: Emergent Life Science & Pharmaceutical Company Abraxis: Emergent Life Science & Pharmaceutical Company Abraxis BioScience, Inc. Michael J. Brunelle, VP Acquisition & Development UGL Equis Mark Berman, Managing Director Brad Gross, Senior Vice President

More information

Reference Materials Nine Month Period Ended December 31, 2018

Reference Materials Nine Month Period Ended December 31, 2018 Reference Materials Nine Month Period Ended December 31, 2018 February 5, 2019 SQUARE ENIX HOLDINGS CO., LTD. Statements made in this document with respect to SQUARE ENIX HOLDINGS CO., LTD. and its consolidated

More information

Confirms 2013 Financial Guidance

Confirms 2013 Financial Guidance Confirms 2013 Financial Guidance PROVIDENCE, R.I.--(BUSINESS WIRE)--Jul. 17, 2013-- Textron Inc. (NYSE: TXT) today reported second quarter 2013 income from continuing operations of $0.40 per share, compared

More information

Proposed Acquisition of Altadis. 18 July 2007 Imperial Tobacco Group PLC

Proposed Acquisition of Altadis. 18 July 2007 Imperial Tobacco Group PLC Proposed Acquisition of Altadis 18 July 2007 Imperial Tobacco Group PLC Gareth Davis Chief Executive Disclaimer This presentation includes certain forward looking statements that identify expectations

More information

April, 2014 GameAccount Network

April, 2014 GameAccount Network April, 2014 Disclaimer Certain statements included in this Presentation contain forward-looking information concerning GameAccount Network's strategy, operations, financial performance or condition, outlook,

More information

the SPD company Dr Clive Simon, Principal, The SPD Company.

the SPD company Dr Clive Simon, Principal, The SPD Company. the SPD company With decades of local and international experience at the coalface, The SPD Company s specialists have built a solid repertoire of in-depth technical knowledge within the highly-regulated

More information

First Quarter 2013 Results May 8, 2013

First Quarter 2013 Results May 8, 2013 First Quarter 2013 Results May 8, 2013 Safe Harbor Disclosure Please review our SEC filings on Form 10-K and Form 10-Q The statements contained in this presentation that are not historical facts are forward-looking

More information

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C FORM 8-K. TEXTRON INC. (Exact name of Registrant as specified in its charter)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C FORM 8-K. TEXTRON INC. (Exact name of Registrant as specified in its charter) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event

More information

FY rd Quarter Financial Results

FY rd Quarter Financial Results FY2013 3 rd Quarter Financial Results April 1 December 31, 2012 KONAMI CORPORATION February 7, 2013 Cautionary statement with respect to forward-looking statements Statements made in this presentation

More information

WOLPERT ASSOCIATES, INC. Strategic Advisory Services Firm Overview

WOLPERT ASSOCIATES, INC. Strategic Advisory Services Firm Overview Strategic Advisory Services 2018 Firm Overview Our Foundational Principles Strategic Advice for Biopharmaceutical, Medical Technology and Life Science sectors A Focus on Strategic Thinking in the Context

More information

International Conference on Pharmaceutical Research and Development June 06-07, 2018 Philadelphia, USA

International Conference on Pharmaceutical Research and Development June 06-07, 2018 Philadelphia, USA International Conference on Pharmaceutical Research and Development,, https://research.pharmaceuticalconferences.com Invitation Dear Attendees, We are glad to announce the International Conference on Pharmaceutical

More information

2Q 2017 Results. 11 Aug 2017 MERMAID MARITIME PUBLIC COMPANY LIMITED

2Q 2017 Results. 11 Aug 2017 MERMAID MARITIME PUBLIC COMPANY LIMITED MERMAID MARITIME PUBLIC COMPANY LIMITED 2Q 2017 Results 11 Aug 2017 1 Disclaimer: The information contained in this document is intended only for use during the presentation and should not be disseminated

More information

China Ophthalmic Hospital Industry Report, May 2013

China Ophthalmic Hospital Industry Report, May 2013 China Ophthalmic Hospital Industry Report, 2012-2015 May 2013 STUDY GOAL AND OBJECTIVES This report provides the industry executives with strategically significant competitor information, analysis, insight

More information

Harborview Medical Center, Board of Trustees records,

Harborview Medical Center, Board of Trustees records, Harborview Medical Center, Board of Trustees records, 1946-2007 Overview of the Collection Creator Harborview Medical Center (Seattle, Wash.). Board of Trustees Title Harborview Medical Center, Board of

More information

The partner of choice for self-care products

The partner of choice for self-care products The partner of choice for self-care products Venture Life Group plc Full Year Results Presentation 2017 22 March 2018 2017 highlights Revenues up 12% to 16.1m (2016: 14.3m) Gross profit increased 18% to

More information

peace of mind For from development to commercial supply

peace of mind For from development to commercial supply For peace of mind from development to commercial supply aesica-pharma.com weshouldtalk@aesica-pharma.com @aesica CorporateBroEng_v2 0814 @ Aesica 2014 Your full service CDMO Our vision: To be the number

More information

STARBREEZE investor Presentation

STARBREEZE investor Presentation STARBREEZE investor Presentation GP Bullhound Nordic Tech Tour, 7 December 2017 Slide / 1 Introduction to starbreeze outline Starbreeze games and publishing Virtual reality Slide / 2 Financial overview

More information

Textron Reports Second Quarter 2014 Income from Continuing Operations of $0.51 per Share, up 27.5%; Revenues up 23.5%

Textron Reports Second Quarter 2014 Income from Continuing Operations of $0.51 per Share, up 27.5%; Revenues up 23.5% Textron Reports Second Quarter 2014 Income from Continuing Operations of $0.51 per Share, up 27.5%; Revenues up 23.5% 07/16/2014 PROVIDENCE, R.I.--(BUSINESS WIRE)-- Textron Inc. (NYSE: TXT) today reported

More information

Investor Presentation & Financial Highlights. May 2018

Investor Presentation & Financial Highlights. May 2018 Investor Presentation & Financial Highlights May 2018 Forward Looking Statements Certain statements in this release are "forward-looking" and as such are subject to numerous risks and uncertainties. Actual

More information

Dealdoc. Acquisition agreement for Gambro. Baxter International Gambro. Dec , Wildwood Ventures Ltd. All rights reserved.

Dealdoc. Acquisition agreement for Gambro. Baxter International Gambro. Dec , Wildwood Ventures Ltd. All rights reserved. Dealdoc Acquisition agreement for Gambro Baxter International Gambro Dec 04 2012 Acquisition agreement for Gambro Companies: Baxter International Gambro Announcement date: Dec 04 2012 Deal value, US$m:

More information

Transforming Surgical Robotics. 34 th Annual J.P. Morgan Healthcare Conference January 14, 2016

Transforming Surgical Robotics. 34 th Annual J.P. Morgan Healthcare Conference January 14, 2016 1 Transforming Surgical Robotics 34 th Annual J.P. Morgan Healthcare Conference January 14, 2016 Forward Looking Statements 2 This presentation includes statements relating to TransEnterix s current regulatory

More information

Analysts Ideas of the Week CardioComm Solutions - ECG Software Management

Analysts Ideas of the Week CardioComm Solutions - ECG Software Management Week of August 29, 2016 Analysts Ideas of the Week CardioComm Solutions - ECG Software Management www.researchfrc.com Sid Rajeev, B.Tech, MBA, CFA Head of Research CardioComm Solutions - ECG Software Management

More information

KKR & Co. Inc. Goldman Sachs U.S. Financial Services Conference December 4, 2018

KKR & Co. Inc. Goldman Sachs U.S. Financial Services Conference December 4, 2018 KKR & Co. Inc. Goldman Sachs U.S. Financial Services Conference December 4, 2018 KKR Today Private Markets Public Markets Capital Markets Principal Activities $104bn AUM $91bn AUM Global Franchise $19bn

More information